(HealthDay)—Men exposed to antidiabetic medications do not have different prostate-specific antigen (PSA) levels, and prostate cancer detection rates at biopsy do not differ regardless of trigger PSA levels, according to a study published online Nov. 6 in JAMA Network Open. Kerri Beckmann, Ph.D., from King’s College London, and colleagues examined the correlations of antidiabetic medication...
Tag: <span>prostate-specific antigen (PSA)</span>
Post
Thousands of men with prostate cancer get risky treatment they don’t need. New approaches could curb that
Precise MD uses fluorescent biomarkers and other features to tell harmless prostate cancer cells from aggressive ones.MOUNT SINAIThey look like glowing jade necklaces of such unearthly brilliance they could be a Ming emperor’s. But if Dr. Gerardo Fernandez is right, the green fluorescent images of prostate cells could be even more valuable, at least to...
Post
Should you get screened for prostate cancer? We break down the latest advice
A panel of experts in preventive medicine released a draft proposal Tuesday on screening for prostate cancer. “Another one?” you may ask, remembering an earlier recommendation. Don’t worry; we’re here to help you avoid whiplash: What’s new? What was emphatic before is wishy-washy now. The last time the US Preventive Services Task Force weighed in on prostate cancer...